137 related articles for article (PubMed ID: 27978527)
41. Enhancement of substrate-gated Cl- currents via rat glutamate transporter EAAT4 by PMA.
Fang H; Huang Y; Zuo Z
Am J Physiol Cell Physiol; 2006 May; 290(5):C1334-40. PubMed ID: 16601148
[TBL] [Abstract][Full Text] [Related]
42. Riluzole attenuates excitatory amino acid transporter type 3 activity in Xenopus oocytes via protein kinase C inhibition.
Choi JS; Ryu JH; Zuo Z; Yang SM; Chang HW; Do SH
Eur J Pharmacol; 2013 Aug; 713(1-3):39-43. PubMed ID: 23680119
[TBL] [Abstract][Full Text] [Related]
43. Niflumic acid modulates uncoupled substrate-gated conductances in the human glutamate transporter EAAT4.
Poulsen MV; Vandenberg RJ
J Physiol; 2001 Jul; 534(Pt 1):159-67. PubMed ID: 11432999
[TBL] [Abstract][Full Text] [Related]
44. Expression of GFP-tagged neuronal glutamate transporters in cerebellar Purkinje neurons.
Meera P; Dodson PD; Karakossian MH; Otis TS
Neuropharmacology; 2005 Nov; 49(6):883-9. PubMed ID: 16212990
[TBL] [Abstract][Full Text] [Related]
45. 1,25-Dihydroxyvitamin D induces the glutamate transporter SLC1A1 and alters glutamate handling in non-transformed mammary cells.
Beaudin S; Welsh J
Mol Cell Endocrinol; 2016 Mar; 424():34-41. PubMed ID: 26774511
[TBL] [Abstract][Full Text] [Related]
46. Effects of volatile anesthetics on glutamate transporter, excitatory amino acid transporter type 3: the role of protein kinase C.
Do SH; Kamatchi GL; Washington JM; Zuo Z
Anesthesiology; 2002 Jun; 96(6):1492-7. PubMed ID: 12170065
[TBL] [Abstract][Full Text] [Related]
47. Critical role of s465 in protein kinase C-increased rat glutamate transporter type 3 activity.
Baik HJ; Huang Y; Washington JM; Zuo Z
Int J Neurosci; 2009; 119(9):1419-28. PubMed ID: 19922365
[TBL] [Abstract][Full Text] [Related]
48. Progesterone increases the activity of glutamate transporter type 3 expressed in Xenopus oocytes.
Son I; Shin HJ; Ryu JH; Kim HK; Do SH; Zuo Z
Eur J Pharmacol; 2013 Sep; 715(1-3):414-9. PubMed ID: 23602688
[TBL] [Abstract][Full Text] [Related]
49. Volatile anesthetics attenuate oxidative stress-reduced activity of glutamate transporter type 3.
Lee SA; Choi JG; Zuo Z
Anesth Analg; 2009 Nov; 109(5):1506-10. PubMed ID: 19843789
[TBL] [Abstract][Full Text] [Related]
50. Effects of pregabalin on the activity of glutamate transporter type 3.
Ryu JH; Lee PB; Kim JH; Do SH; Kim CS
Br J Anaesth; 2012 Aug; 109(2):234-9. PubMed ID: 22511482
[TBL] [Abstract][Full Text] [Related]
51. Up-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by ß-Klotho.
Warsi J; Abousaab A; Lang F
Neurosignals; 2015; 23(1):59-70. PubMed ID: 26684854
[TBL] [Abstract][Full Text] [Related]
52. Doxepin and imipramine but not fluoxetine reduce the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes.
Park HJ; Baik HJ; Kim DY; Lee GY; Woo JH; Zuo Z; Chung RK
BMC Anesthesiol; 2015 Aug; 15():116. PubMed ID: 26253075
[TBL] [Abstract][Full Text] [Related]
53. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder.
McCullumsmith RE; Meador-Woodruff JH
Neuropsychopharmacology; 2002 Mar; 26(3):368-75. PubMed ID: 11850151
[TBL] [Abstract][Full Text] [Related]
54. The glutamate-activated anion conductance in excitatory amino acid transporters is gated independently by the individual subunits.
Koch HP; Brown RL; Larsson HP
J Neurosci; 2007 Mar; 27(11):2943-7. PubMed ID: 17360917
[TBL] [Abstract][Full Text] [Related]
55. Intersubunit interactions in EAAT4 glutamate transporters.
Torres-Salazar D; Fahlke C
J Neurosci; 2006 Jul; 26(28):7513-22. PubMed ID: 16837599
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of peptide transporters PEPT1 and PEPT2 by Janus kinase JAK2.
Hosseinzadeh Z; Dong L; Bhavsar SK; Warsi J; Almilaji A; Lang F
Cell Physiol Biochem; 2013; 31(4-5):673-82. PubMed ID: 23711493
[TBL] [Abstract][Full Text] [Related]
57. The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3.
Esslinger CS; Agarwal S; Gerdes J; Wilson PA; Davis ES; Awes AN; O'Brien E; Mavencamp T; Koch HP; Poulsen DJ; Rhoderick JF; Chamberlin AR; Kavanaugh MP; Bridges RJ
Neuropharmacology; 2005 Nov; 49(6):850-61. PubMed ID: 16183084
[TBL] [Abstract][Full Text] [Related]
58. Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease.
Bianchi MG; Bardelli D; Chiu M; Bussolati O
Cell Mol Life Sci; 2014 Jun; 71(11):2001-15. PubMed ID: 24162932
[TBL] [Abstract][Full Text] [Related]
59. Up-regulation of the betaine/GABA transporter BGT1 by JAK2.
Hosseinzadeh Z; Shojaiefard M; Bhavsar SK; Lang F
Biochem Biophys Res Commun; 2012 Mar; 420(1):172-7. PubMed ID: 22405821
[TBL] [Abstract][Full Text] [Related]
60. The glutamate transporter subtypes EAAT4 and EAATs 1-3 transport glutamate with dramatically different kinetics and voltage dependence but share a common uptake mechanism.
Mim C; Balani P; Rauen T; Grewer C
J Gen Physiol; 2005 Dec; 126(6):571-89. PubMed ID: 16316976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
